SRDX
SRDX Real Time Price USDRecent trades of SRDX by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in SRDX holdings by institutional investors
Quarterly net insider trading by SRDX's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
SRDX Estimated quarterly lobbying spending
SRDX Revenue by Segment or Geography
New SRDX patent grants
-
Patent Title: Helical strain relief device Jan. 04, 2022
-
Patent Title: Composition and method for delivery of hydrophobic active agents Jun. 19, 2018
-
Patent Title: Photoactivatable crosslinker Jun. 12, 2018
-
Patent Title: Controlled release matrix barrier structure for subcutaneous medical devices Jun. 12, 2018
-
Patent Title: Helical strain relief device May. 15, 2018
-
Patent Title: Macrolide particulates, methods for preparation, and medical devices associated therewith Apr. 24, 2018
-
Patent Title: Insertable medical devices having microparticulate-associated elastic substrates and methods for drug delivery Feb. 20, 2018
-
Patent Title: Delivery of hydrophobic active agent particles Jan. 09, 2018
-
Patent Title: Apparatus and methods for coating medical devices Nov. 28, 2017
-
Patent Title: Coatings with crystallized active agent(s) and methods Oct. 24, 2017
-
Patent Title: Solvent methods for preparing crystalline macrolide particulates, compositions, and articles containing particulates Sep. 26, 2017
-
Patent Title: Delivery of coated hydrophobic active agent particles Sep. 12, 2017
-
Patent Title: Lubricious medical device coating with low particulates Aug. 22, 2017
-
Patent Title: Insertable medical devices having microparticulate-associated elastic substrates and methods for drug delivery Jun. 06, 2017
-
Patent Title: Coatings with crystallized active agent(s) and methods May. 16, 2017
-
Patent Title: Cell attachment coatings and methods using phosphorous-containing photoreagent Apr. 25, 2017
-
Patent Title: Stilbene-based reactive compounds, polymeric matrices formed therefrom, and articles visualizable by fluorescence Apr. 25, 2017
-
Patent Title: Apparatus and methods for coating medical devices Apr. 18, 2017
-
Patent Title: Terpolymers as pressure-sensitive adhesives Mar. 21, 2017
-
Patent Title: Method and apparatus for coating balloon catheters Feb. 28, 2017
-
Patent Title: Composition and method for delivery of hydrophobic active agents Jan. 31, 2017
-
Patent Title: Advanced coating apparatus and method Dec. 27, 2016
-
Patent Title: Photoactivatable crosslinker Nov. 08, 2016
-
Patent Title: Macrolide particulates, methods for preparation, and medical devices associated therewith Sep. 13, 2016
-
Patent Title: Coatings with crystallized active agent(s) and methods Aug. 30, 2016
-
Patent Title: Biodegradable terpolymers and terpolymer blends as pressure-sensitive adhesives Aug. 16, 2016
-
Patent Title: Implantable suction cup composites and implants comprising same Aug. 16, 2016
-
Patent Title: Boron-containing linking agents Aug. 09, 2016
-
Patent Title: Bioerodable poly(etheresteramides) and medical article uses Jun. 28, 2016
-
Patent Title: Coating application system with shaped mandrel Jun. 14, 2016
-
Patent Title: Method and apparatus for coating balloon catheters Mar. 29, 2016
-
Patent Title: Coating apparatus and methods Mar. 15, 2016
-
Patent Title: Wound packing device and methods Oct. 13, 2015
-
Patent Title: Viscous terpolymers as drug delivery platform Jul. 28, 2015
-
Patent Title: System for forming a biocompatible foam using polymerizable alpha(1-4)glucopyranose polymers and gas-producing component Apr. 07, 2015
-
Patent Title: Elastic implantable composites and implants comprising same Mar. 10, 2015
-
Patent Title: Combination degradable and non-degradable matrices for active agent delivery Mar. 03, 2015
-
Patent Title: Catheter assembly with guard Feb. 24, 2015
-
Patent Title: Hydrophilic polymeric coatings for medical articles with visualization moiety Feb. 17, 2015
-
Patent Title: Insertable medical devices having microparticulate-associated elastic substrates and methods for drug delivery Feb. 10, 2015
-
Patent Title: Device coated with glycogen particles comprising nucleic acid complexes Jan. 20, 2015
-
Patent Title: Fluorinated polymers and lubricious coatings Jan. 13, 2015
-
Patent Title: Hydrophobic polysaccharides with silyl ether linkages having enhanced degradation and medical articles made therefrom Jan. 13, 2015
-
Patent Title: Compositions and methods for in vitro diagnostic tests including sulfonic acid Jan. 06, 2015
-
Patent Title: Lipid coating for medical devices delivering bioactive agent Jan. 06, 2015
-
Patent Title: Functionalized polysaccharides for active agent delivery Dec. 02, 2014
-
Patent Title: Photoactivatable crosslinker Nov. 18, 2014
-
Patent Title: Particles for delivery of nucleic acids and related devices and methods Nov. 11, 2014
-
Patent Title: Glycerol ester active agent delivery systems and methods Oct. 28, 2014
-
Patent Title: Silane-functionalized hydrophobic α(1→4)glucopyranose polymers and polymeric matrices for implantation or injection Aug. 12, 2014
Federal grants, loans, and purchases
Estimated quarterly amount awarded to SRDX from public contracts
Recent insights relating to SRDX
Recent picks made for SRDX stock on CNBC
ETFs with the largest estimated holdings in SRDX
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $SRDX stock a Buy, Sell, or Hold?
- What is the price target for $SRDX stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $SRDX stock?
- Who owns the most shares of $SRDX stock?
- What funds own $SRDX stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view SRDX Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
No description available